JANE STREET GROUP, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,535,459
-29.9%
724,273
+57.4%
0.00%
-100.0%
Q2 2023$2,190,942
+304.5%
460,282
+384.4%
0.00%
Q1 2023$541,660
-65.4%
95,028
-38.7%
0.00%
-100.0%
Q4 2022$1,563,416
+485.5%
154,947
+1199.5%
0.00%
Q3 2022$267,000
-51.5%
11,924
-46.3%
0.00%
Q2 2022$550,000
-59.7%
22,195
-36.9%
0.00%
Q1 2022$1,365,000
-78.5%
35,200
-67.5%
0.00%
-100.0%
Q4 2021$6,338,000
+244.3%
108,335
+248.7%
0.00%
Q3 2021$1,841,000
-35.3%
31,064
-5.2%
0.00%
-100.0%
Q2 2021$2,845,000
-39.6%
32,776
-42.7%
0.00%
-50.0%
Q1 2021$4,714,000
-22.4%
57,174
-14.4%
0.00%
-33.3%
Q4 2020$6,073,000
+248.6%
66,788
+53.3%
0.00%
+200.0%
Q3 2020$1,742,000
+200.9%
43,575
+158.1%
0.00%
Q2 2020$579,000
+135.4%
16,882
+52.5%
0.00%
Q1 2020$246,000
+1.7%
11,071
-28.9%
0.00%
Q3 2019$242,000
-21.7%
15,562
+2.1%
0.00%
-100.0%
Q2 2019$309,000
+76.6%
15,242
+11.6%
0.00%
Q4 2018$175,000
+6.1%
13,656
+34.8%
0.00%
Q3 2018$165,000
+42.2%
10,127
-0.8%
0.00%
Q2 2018$116,000
+157.8%
10,213
-9.6%
0.00%
Q3 2017$45,000
-41.6%
11,292
-7.4%
0.00%
-100.0%
Q2 2014$77,000
-33.6%
12,200
+2.5%
0.00%0.0%
Q1 2014$116,00011,9000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders